This announcement is a separate document:
昭栄薬品：2024年第2四半期の決算の要約
Shoei Yakuhin: Summary of Financial Results for the second quarter 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.